MYOK News and Press, MyoKardia Inc. From 08/07/19

MyoKardia (NASDAQ: MYOK ): Q2 GAAP EPS of -$0.83 beats by $0.17 . More news on: MyoKardia, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Announces Last Patient to be Enrolled in EXPLORER-HCM Phase 3 during the Week of  August 12 th ; Topline Data Accelerated to 2 nd Quarter 2020 Topline Phase 2 Clinical Data from MAVERICK-HCM and MYK-491 on Track for Fourth Quarter 2019 Company to Host Conference Call and Web...

SOUTH SAN FRANCISCO, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that Taylor Harris, Chief Financial Officer, will present at the 2019 Wedbush PacGrow Healthcare Conference on Wednesday, August 14 th , 2019, at 10:55 a.m. ET in New York, NY. ...

SOUTH SAN FRANCISCO, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), today announced that it will report second quarter 2019 financial and operating results on Wednesday, August 7, 2019. Management will host a conference call and live audio webcast to discuss these...

EXPLORER-HCM Patient Screening Closes Ahead of Schedule – Initial Results Now Anticipated in the Second Quarter of 2020 Royalty Purchase Creates Additional Economic Value for MyoKardia’s Emerging HCM Treatment Portfolio SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLO...

SOUTH SAN FRANCISCO, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced the publication of an article titled, “ Machine Learning Detection of Obstructive Hypertrophic Cardiomyopathy (oHCM) Using a Wearable Biosensor ,” in the Nature Part...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you ca...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , iTunes...

Quick Take BridgeBio ( BBIO ) has filed to raise gross proceeds of up to $225 million from a U.S. IPO, according to an S-1/A registration statement . The group is developing therapeutics for Mendelian diseases, or diseases arising from defects in a single gene as well as cancers with clea...

SOUTH SAN FRANCISCO, Calif., June 18, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious cardiovascular diseases, today announced that Jake Bauer, Chief Business Officer, w...